Composition

Pneumococcal polysaccharide and Non-Typeable Haemophilus influenzae (NTHi) protein D conjugate vaccine, adsorbed Suspension for injection. Each dose (0.5 mL) contains: - Pneumococcal polysaccharide serotype 1(1,2) 1 microgram - Pneumococcal polysaccharide serotype 4(1,2) 3 micrograms - Pneumococcal polysaccharide serotype 5(1,2) 1 microgram - Pneumococcal polysaccharide serotype 6B(1,2) 1 microgram - Pneumococcal polysaccharide serotype 7F(1,2) 1 microgram - Pneumococcal polysaccharide serotype 9V(1,2) 1 microgram - Pneumococcal polysaccharide serotype 14(1,2) 1 microgram - Pneumococcal polysaccharide serotype 18C(1,3) 3 micrograms - Pneumococcal polysaccharide serotype 19F(1,4) 3 micrograms - Pneumococcal polysaccharide serotype 23F(1,2) 1 microgram 1) adsorbed on aluminium phosphate, 0.5 milligram Al^3+ in total 2) conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein, 9–16 micrograms 3) conjugated to tetanus toxoid carrier protein 5–10 micrograms 4) conjugated to diphtheria toxoid carrier protein 3–6 micrograms  

ATC Code/ATCvet Code

J07AL52  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

2 mL (4 Doses) x 100's (in glass vials)  

Product Description

Suspension for injection (injection). The vaccine is a turbid white suspension

Manufacturer Name

Glaxosmithkline Biologicals S.A

Manufacturer Country

BELGIUM  

Approval Date

2023-11-30  

Expiry Date

2028-11-29